RISE Research Institutes of Sweden was recently granted funding from Vinnova for the DOUBLE BARRIER project, which aims to integrate AI-driven multi-omics diagnostics and next-generation prevention strategies to combat bacterial infections and antimicrobial resistance (AMR). The project will allow RISE to develop the concept and strengthen the collaboration with Sahlgrenska University Hospital, Veirulence Ltd, Imperial College London and The National Institutes of Health (USA).
The DOUBLE BARRIER concept builds on DIA-AID (https://dia-aid.com/), winner of the Swedish Sahlgrenska Global Health Hackathon. It addresses one of the greatest challenges of modern medicine: AMR, a growing threat that already causes 1 million deaths annually.
“Our vision is a future where rapid, data-rich multi-omics-based diagnostics, powered by artificial intelligence (AI), enable tailored treatments for infectious diseases, while the generated data guides more effective prevention strategies,” says Francisco Salvà Serra, project manager and researcher at RISE.
The project will be coordinated by RISE, with a total budget of 3,175,000 SEK. Of this, 1,000,000 SEK is funded by Vinnova, and the remaining part is provided in-kind by the UK and US partners.
More about the project 👉 https://lnkd.in/dDqWCner
